Xiangxue Pharmaceutical Co 주식 주식분석 | 주식가격 | 뉴스 | 300147.SZ | CNE100000Y92 | | 2025년 7월

날짜	Xiangxue Pharmaceutical Co 주식 가격
	8.21 undefined
	8.19 undefined
	8.18 undefined
	8.10 undefined
	8.29 undefined
	8.36 undefined
	8.87 undefined
	8.64 undefined
	8.32 undefined
	8.30 undefined
	8.38 undefined
	8.34 undefined
	8.41 undefined
	8.30 undefined
	8.33 undefined
	8.48 undefined
	8.70 undefined
	8.36 undefined
	8.42 undefined
	8.23 undefined
	8.12 undefined
	8.13 undefined

날짜	Xiangxue Pharmaceutical Co 매출	Xiangxue Pharmaceutical Co EBIT	Xiangxue Pharmaceutical Co 이익
2024	1.86 조. undefined	-233.84 백만 undefined	-858.56 백만 undefined
2023	2.3 조. undefined	39.74 백만 undefined	-388.96 백만 undefined
2022	2.19 조. undefined	-181.89 백만 undefined	-533.16 백만 undefined
2021	2.97 조. undefined	-2.24 백만 undefined	-688.47 백만 undefined
2020	3.07 조. undefined	389.3 백만 undefined	98.4 백만 undefined
2019	2.79 조. undefined	263.4 백만 undefined	76.5 백만 undefined
2018	2.5 조. undefined	317.2 백만 undefined	56.4 백만 undefined
2017	2.19 조. undefined	115.3 백만 undefined	65.9 백만 undefined
2016	1.86 조. undefined	118.1 백만 undefined	66 백만 undefined
2015	1.46 조. undefined	217.4 백만 undefined	177.3 백만 undefined
2014	1.52 조. undefined	255.3 백만 undefined	196.8 백만 undefined
2013	1.26 조. undefined	232.1 백만 undefined	158.2 백만 undefined
2012	801 백만 undefined	147 백만 undefined	107.2 백만 undefined
2011	616.1 백만 undefined	102.2 백만 undefined	83.5 백만 undefined
2010	513.4 백만 undefined	101.3 백만 undefined	74.2 백만 undefined
2009	378.6 백만 undefined	71.4 백만 undefined	51 백만 undefined
2008	294.8 백만 undefined	41.7 백만 undefined	35.9 백만 undefined
2007	258.3 백만 undefined	37.1 백만 undefined	30.8 백만 undefined

	매출	EBIT	이익
2007	258.3 백만 CNY	37.1 백만 CNY	30.8 백만 CNY
2008	294.8 백만 CNY	41.7 백만 CNY	35.9 백만 CNY
2009	378.6 백만 CNY	71.4 백만 CNY	51 백만 CNY
2010	513.4 백만 CNY	101.3 백만 CNY	74.2 백만 CNY
2011	616.1 백만 CNY	102.2 백만 CNY	83.5 백만 CNY
2012	801 백만 CNY	147 백만 CNY	107.2 백만 CNY
2013	1.26 조. CNY	232.1 백만 CNY	158.2 백만 CNY
2014	1.52 조. CNY	255.3 백만 CNY	196.8 백만 CNY
2015	1.46 조. CNY	217.4 백만 CNY	177.3 백만 CNY
2016	1.86 조. CNY	118.1 백만 CNY	66 백만 CNY
2017	2.19 조. CNY	115.3 백만 CNY	65.9 백만 CNY
2018	2.5 조. CNY	317.2 백만 CNY	56.4 백만 CNY
2019	2.79 조. CNY	263.4 백만 CNY	76.5 백만 CNY
2020	3.07 조. CNY	389.3 백만 CNY	98.4 백만 CNY
2021	2.97 조. CNY	-2.24 백만 CNY	-688.47 백만 CNY
2022	2.19 조. CNY	-181.89 백만 CNY	-533.16 백만 CNY
2023	2.3 조. CNY	39.74 백만 CNY	-388.96 백만 CNY
2024	1.86 조. CNY	-233.84 백만 CNY	-858.56 백만 CNY

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
0.26	0.29	0.38	0.51	0.62	0.8	1.26	1.52	1.46	1.86	2.19	2.5	2.79	3.07	2.97	2.19	2.3	1.86
-	13.95	28.57	35.71	20.08	30.03	57.43	20.86	-3.94	27.19	17.45	14.49	11.26	10.27	-3.32	-26.36	5.12	-19.18
46.12	51.02	50.53	46.20	45.94	47.69	41.00	41.60	42.62	31.53	29.49	36.46	31.59	32.29	24.95	24.28	32.32	21.91
119	150	191	237	283	382	517	634	624	587	645	913	880	992	741	531	743	407
30	35	51	74	83	107	158	196	177	66	65	56	76	98	-688	-533	-388	-858
-	16.67	45.71	45.10	12.16	28.92	47.66	24.05	-9.69	-62.71	-1.52	-13.85	35.71	28.95	-802.04	-22.53	-27.20	121.13
396.9	396.9	396.9	450.8	602.7	608.6	615.6	609.6	661.5	660.2	661.5	661.5	637.6	661.5	661.36	658.22	661.28	661.28
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022	2023	2024

0.04	0.04	0.09	1.15	0.79	1.29	0.77	0.33	0.68	0.86	2.01	0.93	0.36	0.5	0.37	0.34	0.13	0.14	0.12
0.01	0.01	0.04	0.05	0.06	0.12	0.32	0.4	0.52	0.8	0.81	0.84	0.95	1.04	1.22	1.1	0.6	0.7	0.81
0	0.02	0.03	0.04	0.04	0.06	0.09	0.11	0.16	0.36	1.4	1.28	0.56	0.99	0.35	0.57	0.27	0.21	0.17
19.8	23.6	30.2	54.2	89.4	128.7	224.6	284.3	341.7	503.1	504.5	590.1	756.4	839.8	761.46	761.46	467.07	411.3	340.92
21.1	22.1	32.9	34.4	72.6	90	97.3	123.4	427.7	463.8	149.1	285.3	474.3	353.6	466.92	313.47	233.67	362.64	158.27
0.1	0.12	0.22	1.34	1.05	1.69	1.5	1.25	2.13	2.98	4.87	3.92	3.1	3.72	3.16	3.09	1.69	1.82	1.6
0.4	0.36	0.41	0.44	0.69	1.03	1.3	1.48	1.62	2.87	2.4	2.68	3.46	3.66	5.96	6.01	4.82	4.64	4.26
1.8	1.6	1.5	1.4	1.4	1.3	18.9	168.5	157.2	269.6	334.9	366.2	444.2	668.3	270.21	521.94	486.39	193.16	323.44
0	0	0	0	0	0	0	0	0	0	0	0	0	0	346.04	0	76.47	0	0
0.05	0.07	0.07	0.07	0.11	0.16	0.22	0.24	0.3	0.4	0.56	0.78	0.72	0.97	1.03	1.43	1.37	1.36	1.06
1.4	1.3	1.3	1.2	66.7	66.7	423.7	422.5	422.5	634.5	646.7	644.7	626.6	626.6	266.6	266.6	199.72	199.72	199.72
0.8	1.2	1	1	3	3.8	11.5	29.4	21.9	836.5	427.1	234.4	108.8	127.3	318	67.03	71.07	68.73	49.01
0.45	0.44	0.48	0.51	0.87	1.26	1.98	2.34	2.52	5.01	4.37	4.71	5.36	6.06	8.19	8.29	7.03	6.46	5.9
0.55	0.55	0.7	1.85	1.92	2.95	3.47	3.59	4.65	7.99	9.24	8.63	8.46	9.78	11.35	11.38	8.72	8.28	7.5

81	81	92	123	246	301	392.1	509.6	661.5	661.5	661.5	661.5	661.5	661.5	661.36	661.36	661.28	661.28	661.28
0.01	0.01	0.08	1.06	0.93	0.91	0.84	0.73	2.13	2.13	2.13	2.13	2.09	2.15	2.15	2.15	2.15	2.15	2.15
90.8	94.3	145.2	169.2	215.8	273.7	371.6	505.7	614.2	600.9	666.8	703.4	801.2	825.7	138.42	138.42	-493.1	-882.06	-1,730.88
-0.5	-0.9	-0.8	-0.9	-1	-1	-1.2	-3.6	-2.4	-0.1	-0.7	3.3	-36.5	4.2	814.29	4.11	6.05	6.27	6.28
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.04	-2.04	-11.24	-4.58	-25.56
0.18	0.18	0.32	1.35	1.39	1.48	1.61	1.74	3.41	3.4	3.46	3.5	3.52	3.64	3.76	2.95	2.32	1.93	1.06
0.04	0.07	0.06	0.07	0.07	0.08	0.15	0.18	0.21	0.42	0.41	0.43	0.57	0.68	1.12	1.11	0.97	1.08	1.15
4.7	6.8	4.3	6.9	8.1	31	31.3	31.8	30.7	45.7	55.5	54.2	42.7	51.9	72.82	79	121.27	128	229.37
0.04	0.05	0.07	0.06	0.05	0.05	0.35	0.22	0.25	1.14	1.07	0.4	0.36	0.37	2.83	1.82	1.57	1.72	1.91
0.04	0.12	0.13	0.24	0.15	0.51	0.42	0.63	0.07	1.2	1.7	1.48	1.95	3.15	2.47	3.48	2.49	1.89	1.81
12.5	25	25	25	12.5	40	60	80	0	500.1	0	852.9	331.2	134	450.5	450.5	79.97	343.95	286.33
0.14	0.27	0.29	0.4	0.29	0.71	1.02	1.14	0.56	3.3	3.24	3.22	3.26	4.38	6.94	6.94	5.23	5.16	5.38
0.09	0.06	0.04	0.04	0.18	0.67	0.72	0.54	0.5	0.75	1.82	1.31	0.94	0.95	0.53	0.53	0.45	0.59	0.6
0	0	0	0	0	0	0	0	0	0	0	14.5	0	0	3.73	3.73	6.62	9.46	8.12
138	26.5	26.7	29.7	27.7	30.4	30.7	42.8	43.2	249.2	299.8	68	148.7	198.2	-6,347.27	143.51	230.41	205.35	67.92
0.23	0.09	0.07	0.07	0.21	0.71	0.75	0.58	0.54	1	2.12	1.39	1.09	1.15	-5.81	0.68	0.69	0.81	0.68
0.36	0.36	0.36	0.48	0.5	1.41	1.76	1.72	1.11	4.3	5.36	4.61	4.35	5.53	1.13	7.62	5.92	5.97	6.06
0.54	0.54	0.68	1.82	1.9	2.9	3.37	3.46	4.51	7.7	8.82	8.12	7.87	9.16	4.9	10.58	8.24	7.9	7.12

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-688	0	-533
0	0	0	0	0	0	0	0	0	0	0	0	0	0	188	0	238
0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	-16
-29	-75	-91	-86	-113	-222	-181	-386	-322	-487	-365	-566	-491	-377	118	-657	-436
0	0	0	0	0	0	0	0	0	0	0	0	0	0	662	0	326
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-29	-34	-42	-54	-72	-75	-123	-117	-130	-135	-115	-105	-90	-111	116	-116	-65
138	55	46	45	29	118	328	165	159	198	109	91	83	257	257	257	227
-144	-137	-52	-56	-230	-418	-318	-243	-277	-1,966	-777	-495	-661	-707	-562	-562	-367
-93	-82	-52	-56	-368	-451	-578	-503	-612	-2,569	-673	219	848	-1,238	-112	-112	379
0.05	0.05	0	0	-0.14	-0.03	-0.26	-0.26	-0.34	-0.6	0.1	0.72	1.51	-0.53	0.45	0.45	0.75
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.01	0.02	0.03	0.12	0.01	0.86	-0.16	0.04	-0.63	2.34	1.12	-0.53	-0.9	1.2	-0.27	-0.68	-0.49
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.01	0.01	0.06	1.07	-0.02	0.84	-0.29	-0.11	0.79	2.22	0.96	-0.76	-1.03	1.12	-0.45	-0.45	-0.65
-0	0.04	0.05	1.01	0.02	0.06	0.02	-0	1.56	0.03	0.02	-0.02	0.11	0.13	0.04	0.45	0.02
-17	-42	-11	-65	-54	-80	-147	-150	-135	-157	-172	-207	-239	-204	-216	-216	-175
0.23	0.15	0.24	1.24	-0.15	0.92	0.09	0.22	0.95	0.67	0.99	0.32	0.56	0.89	0.73	0.73	0.68
-6.7	-82	-6.7	-11.4	-201.1	-299.2	9.9	-78.3	-117.1	-1,767.5	-668.4	-404.3	-578.1	-450.2	-305.18	-305.18	-139.89
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Xiangxue Pharmaceutical Co 브루토마진	Xiangxue Pharmaceutical Co 이익 마진	Xiangxue Pharmaceutical Co EBIT-마진	Xiangxue Pharmaceutical Co 이익 마진
2024	21.93 %	-12.58 %	-46.19 %
2023	32.33 %	1.73 %	-16.92 %
2022	24.32 %	-8.32 %	-24.38 %
2021	24.96 %	-0.08 %	-23.18 %
2020	32.31 %	12.67 %	3.2 %
2019	31.61 %	9.45 %	2.75 %
2018	36.46 %	12.67 %	2.25 %
2017	29.5 %	5.27 %	3.01 %
2016	31.52 %	6.34 %	3.54 %
2015	42.64 %	14.84 %	12.11 %
2014	41.63 %	16.75 %	12.91 %
2013	41.06 %	18.4 %	12.54 %
2012	47.73 %	18.35 %	13.38 %
2011	46.03 %	16.59 %	13.55 %
2010	46.3 %	19.73 %	14.45 %
2009	50.45 %	18.86 %	13.47 %
2008	51.15 %	14.15 %	12.18 %
2007	46.3 %	14.36 %	11.92 %

	브루토마진	EBIT-마진	이익 마진
2007	46.3 %	14.36 %	11.92 %
2008	51.15 %	14.15 %	12.18 %
2009	50.45 %	18.86 %	13.47 %
2010	46.3 %	19.73 %	14.45 %
2011	46.03 %	16.59 %	13.55 %
2012	47.73 %	18.35 %	13.38 %
2013	41.06 %	18.4 %	12.54 %
2014	41.63 %	16.75 %	12.91 %
2015	42.64 %	14.84 %	12.11 %
2016	31.52 %	6.34 %	3.54 %
2017	29.5 %	5.27 %	3.01 %
2018	36.46 %	12.67 %	2.25 %
2019	31.61 %	9.45 %	2.75 %
2020	32.31 %	12.67 %	3.2 %
2021	24.96 %	-0.08 %	-23.18 %
2022	24.32 %	-8.32 %	-24.38 %
2023	32.33 %	1.73 %	-16.92 %
2024	21.93 %	-12.58 %	-46.19 %

날짜	Xiangxue Pharmaceutical Co 주당 매출	Xiangxue Pharmaceutical Co EBIT 당 주식	Xiangxue Pharmaceutical Co 주당 이익
2024	2.81 undefined	-0.35 undefined	-1.3 undefined
2023	3.48 undefined	0.06 undefined	-0.59 undefined
2022	3.32 undefined	-0.28 undefined	-0.81 undefined
2021	4.49 undefined	-0 undefined	-1.04 undefined
2020	4.64 undefined	0.59 undefined	0.15 undefined
2019	4.37 undefined	0.41 undefined	0.12 undefined
2018	3.79 undefined	0.48 undefined	0.09 undefined
2017	3.31 undefined	0.17 undefined	0.1 undefined
2016	2.82 undefined	0.18 undefined	0.1 undefined
2015	2.21 undefined	0.33 undefined	0.27 undefined
2014	2.5 undefined	0.42 undefined	0.32 undefined
2013	2.05 undefined	0.38 undefined	0.26 undefined
2012	1.32 undefined	0.24 undefined	0.18 undefined
2011	1.02 undefined	0.17 undefined	0.14 undefined
2010	1.14 undefined	0.22 undefined	0.16 undefined
2009	0.95 undefined	0.18 undefined	0.13 undefined
2008	0.74 undefined	0.11 undefined	0.09 undefined
2007	0.65 undefined	0.09 undefined	0.08 undefined

	주당 매출	EBIT 당 주식	주당 이익
2007	0.65 CNY	0.09 CNY	0.08 CNY
2008	0.74 CNY	0.11 CNY	0.09 CNY
2009	0.95 CNY	0.18 CNY	0.13 CNY
2010	1.14 CNY	0.22 CNY	0.16 CNY
2011	1.02 CNY	0.17 CNY	0.14 CNY
2012	1.32 CNY	0.24 CNY	0.18 CNY
2013	2.05 CNY	0.38 CNY	0.26 CNY
2014	2.5 CNY	0.42 CNY	0.32 CNY
2015	2.21 CNY	0.33 CNY	0.27 CNY
2016	2.82 CNY	0.18 CNY	0.1 CNY
2017	3.31 CNY	0.17 CNY	0.1 CNY
2018	3.79 CNY	0.48 CNY	0.09 CNY
2019	4.37 CNY	0.41 CNY	0.12 CNY
2020	4.64 CNY	0.59 CNY	0.15 CNY
2021	4.49 CNY	-0 CNY	-1.04 CNY
2022	3.32 CNY	-0.28 CNY	-0.81 CNY
2023	3.48 CNY	0.06 CNY	-0.59 CNY
2024	2.81 CNY	-0.35 CNY	-1.3 CNY

	주식 수량
2007	396.9 백만 Aktien
2008	396.9 백만 Aktien
2009	396.9 백만 Aktien
2010	450.8 백만 Aktien
2011	602.7 백만 Aktien
2012	608.6 백만 Aktien
2013	615.6 백만 Aktien
2014	609.6 백만 Aktien
2015	661.5 백만 Aktien
2016	660.2 백만 Aktien
2017	661.5 백만 Aktien
2018	661.5 백만 Aktien
2019	637.6 백만 Aktien
2020	661.5 백만 Aktien
2021	661.36 백만 Aktien
2022	658.22 백만 Aktien
2023	661.28 백만 Aktien
2024	661.28 백만 Aktien

날짜	Xiangxue Pharmaceutical Co 배당금
2020	0.05 undefined
2019	0.03 undefined
2018	0.03 undefined
2016	0.12 undefined
2015	0.11 undefined
2014	0.1 undefined
2013	0.12 undefined
2012	0.1 undefined
2011	0.07 undefined

	배당금	배당금 (추정)
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0.07 CNY	0 CNY
2012	0.1 CNY	0 CNY
2013	0.12 CNY	0 CNY
2014	0.1 CNY	0 CNY
2015	0.11 CNY	0 CNY
2016	0.12 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0.03 CNY	0 CNY
2019	0.03 CNY	0 CNY
2020	0.05 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0 CNY	0 CNY
2023	0 CNY	0 CNY
2024	0 CNY	0 CNY

날짜	Xiangxue Pharmaceutical Co 배당률
2024	30.44 %
2023	30.5 %
2022	29.95 %
2021	30.86 %
2020	30.67 %
2019	28.33 %
2018	33.59 %
2017	30.86 %
2016	120 %
2015	41.39 %
2014	31.84 %
2013	45.5 %
2012	54.78 %
2011	52.86 %
2010	30.86 %
2009	30.86 %
2008	30.86 %
2007	30.86 %

	배당률
2007	30.86 %
2008	30.86 %
2009	30.86 %
2010	30.86 %
2011	52.86 %
2012	54.78 %
2013	45.5 %
2014	31.84 %
2015	41.39 %
2016	120 %
2017	30.86 %
2018	33.59 %
2019	28.33 %
2020	30.67 %
2021	30.86 %
2022	29.95 %
2023	30.5 %
2024	30.44 %

EPS-예상치	EPS-실제	보고 분기
0.18	0.1 (-44.99 %)	2015 Q2
0.16	0.07 (-53.09 %)	2014 Q4
0.18	0.1 (-43.43 %)	2014 Q3
0.15	0.11 (-24.1 %)	2014 Q2
0.08	0.08 (7.22 %)	2013 Q4
0.1	0.08 (-14.23 %)	2013 Q3
0.09	0.04 (-49.12 %)	2013 Q2
0.12	0.04 (-61.34 %)	2012 Q4

%-지분	이름	주식	변경
22.59408 %	Guangzhou Kunlun Investment Co., Ltd.	149,409,921	0
4.05763 %	Guangzhou Luogang Water Supply Co., Ltd.	26,832,260	0
0.45953 %	Barclays Bank PLC	3,038,763	3,038,763
0.45902 %	China International Capital Corporation Asset Management Ltd.	3,035,400	1,056,948
0.39123 %	China Universal Asset Management Co., Ltd.	2,587,100	342,300
0.33940 %	CITIC Securities Co., Ltd. (Asset Management)	2,244,368	-2,766,361
0.29260 %	Xu (Chang)	1,934,880	1,934,880
0.12532 %	Penghua Fund Management Co., Ltd.	828,700	-309,700
0.06965 %	The Vanguard Group, Inc.	460,600	0
0.06072 %	Huatai-PineBridge Fund Management Co., Ltd.	401,500	45,600
0.05960 %	Zeng (Lun)	394,137	0
0.04624 %	Kang (Zhiying)	305,787	0
0.03050 %	Xu (Li)	201,701	0
0.02835 %	Huang (Weihua)	187,484	-60,000
0.02741 %	Mo (Ziyu)	181,255	0
0.02012 %	Tan (Wenhui)	133,031	0
0.01211 %	Yinhua Fund Management Co., Ltd.	80,100	8,000
0.00907 %	Chen (Wenjin)	60,000	0
0.00733 %	China Southern Asset Management Co. Ltd.	48,500	41,100
0.00227 %	Niu (Xiaoyan)	15,000	0
0.00166 %	INVESCO Great Wall Fund Management Co. Ltd.	11,000	-17,700
0.00071 %	China Asset Management Co., Ltd.	4,700	4,700
0.00050 %	Guotai Asset Management Co., Ltd.	3,300	1,200
0.00045 %	Vanguard Investments Australia Ltd.	2,943	-736
0 %	Xingyin Fund Management Co., Ltd.	0	-10,200
0 %	Shanghai Haitong Securities Asset Management Ltd.	0	-43,300
0 %	Hongde Fund Management Co., Ltd.	0	-40,200
0 %	GFund Management Co., Ltd.	0	-645,300
0 %	Tianhong Asset Management Co., Ltd.	0	-71,600
0 %	China CITIC Financial Asset Management Co.,Ltd	0	-60,000
0 %	SWS MU Fund Management Co., Ltd.	0	-50,000
0 %	Lion Fund Management Co., Ltd.	0	-900
0 %	Hwabao WP Fund Management Co., Ltd.	0	-91,600
0 %	GF Fund Management Co., Ltd.	0	-194,700
0 %	Rongtong Fund Management Co., Ltd.	0	-11,200
0 %	HFT Investment Management Co., Ltd.	0	-430,400
0 %	Harvest Fund Management Co., Ltd.	0	-7,700
0 %	Sealand Securities Co., Ltd.	0	-26,700

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
China Meheco Group A	공급업체고객	0,87	0,75	0,45	0,24	0,12	0,10
Zhangzhou Pientzehuang A	공급업체고객	0,40	0,24	0,31	0,01	0,04	-0,68
Guangzhou Baiyunshan H	공급업체고객	0,30	0,49	0,11	0,45	0,61	0,06
Athenex	공급업체고객	-0,32	-0,45	0,80	0,14	0,38	0,85

What values and corporate philosophy does Xiangxue Pharmaceutical Co represent?

Xiangxue Pharmaceutical Co Ltd represents values of innovation, integrity, and sustainability in the pharmaceutical industry. With a strong corporate philosophy focused on research and development, Xiangxue Pharmaceutical strives to provide high-quality and affordable healthcare solutions to improve the lives of people globally. The company's commitment to technological advancements and scientific excellence enables them to develop cutting-edge pharmaceutical products and treatments. Xiangxue Pharmaceutical embraces a customer-centric approach, ensuring the well-being of patients and addressing unmet medical needs. By adhering to ethical business practices and promoting social responsibility, Xiangxue Pharmaceutical serves as a trusted partner in the healthcare sector.

In which countries and regions is Xiangxue Pharmaceutical Co primarily present?

Xiangxue Pharmaceutical Co Ltd is primarily present in China.

What significant milestones has the company Xiangxue Pharmaceutical Co achieved?

Xiangxue Pharmaceutical Co Ltd has achieved several significant milestones. The company has successfully developed and launched a range of innovative pharmaceutical products, gaining recognition within the industry. Xiangxue Pharmaceutical Co Ltd has also established strategic partnerships with leading international pharmaceutical companies, expanding its global reach and collaboration opportunities. Additionally, the company has shown consistent growth with its financial performance, demonstrating strong market presence and investor confidence. Overall, Xiangxue Pharmaceutical Co Ltd has made notable advancements, solidifying its position as a prominent player in the pharmaceutical sector.

What is the history and background of the company Xiangxue Pharmaceutical Co?

Xiangxue Pharmaceutical Co Ltd is a leading Chinese pharmaceutical company with a rich history and background. Founded in 1986, the company has grown into a renowned player in the healthcare industry. Xiangxue Pharmaceutical focuses on research, development, manufacturing, and marketing of innovative drugs, particularly in the fields of antibiotics, anti-tumor agents, and cardiovascular drugs. With its commitment to quality and innovation, the company has gained recognition both domestically and internationally. Xiangxue Pharmaceutical's dedication to improving human health and providing cutting-edge medical solutions sets it apart in the pharmaceutical sector.

Who are the main competitors of Xiangxue Pharmaceutical Co in the market?

The main competitors of Xiangxue Pharmaceutical Co Ltd in the market include companies such as Jiangsu Hengrui Medicine Co Ltd, Shanghai Fosun Pharmaceutical Group Co Ltd, and Beijing SL Pharmaceutical Co Ltd. These companies play a significant role in the pharmaceutical industry and compete with Xiangxue Pharmaceutical Co Ltd in terms of product offerings, market share, and innovation. It is essential for Xiangxue Pharmaceutical Co Ltd to continuously evaluate and differentiate its products and services to maintain a competitive edge with these prominent market players.

In which industries is Xiangxue Pharmaceutical Co primarily active?

Xiangxue Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry. With a focus on research, development, manufacturing, and distribution of pharmaceutical products, Xiangxue Pharmaceutical plays a pivotal role in improving healthcare outcomes. Their expertise spans across various therapeutic areas, including cardiovascular, respiratory, gastrointestinal, and geriatric medicines. By continuously innovating and adhering to strict quality standards, Xiangxue Pharmaceutical strives to deliver safe and effective treatments to patients worldwide. With their strong presence in the pharmaceutical sector, Xiangxue Pharmaceutical remains committed to advancing healthcare and making a positive impact on people's lives.

What is the business model of Xiangxue Pharmaceutical Co?

The business model of Xiangxue Pharmaceutical Co Ltd revolves around the research, development, manufacturing, and sales of pharmaceutical products. As a leading pharmaceutical company, Xiangxue Pharmaceutical focuses on areas such as innovative drug development, generics, and biological products. The company's business model emphasizes a comprehensive approach to healthcare, including both traditional Chinese medicine and Western medicine. Xiangxue Pharmaceutical Co Ltd seeks to provide high-quality, affordable medications and medical solutions to improve public health.

Xiangxue Pharmaceutical Co 2025의 P/E 비율은 얼마입니까?

Xiangxue Pharmaceutical Co에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Xiangxue Pharmaceutical Co 2025의 KUV는 얼마입니까?

Xiangxue Pharmaceutical Co에 대한 현재 KUV는 계산할 수 없습니다.

Xiangxue Pharmaceutical Co의 AlleAktien 품질 점수는 얼마인가요?

Xiangxue Pharmaceutical Co에 대한 AlleAktien 품질 점수는 3/10입니다.

Xiangxue Pharmaceutical Co 2025의 매출은 얼마인가요?

Xiangxue Pharmaceutical Co에 대한 현재 매출은 계산할 수 없습니다.

Xiangxue Pharmaceutical Co 2025의 이익은 얼마인가요?

Xiangxue Pharmaceutical Co의 현재 이익을 계산할 수 없습니다.

Xiangxue Pharmaceutical Co은 무엇을 하나요?

Xiangxue Pharmaceutical Co Ltd is a Chinese company that specializes in the manufacturing and sale of pharmaceuticals and health products. The company was founded in 1997 and has been listed on the Shanghai Stock Exchange since 2003. The business model of Xiangxue Pharmaceutical includes several divisions, including the development, manufacturing, and marketing of pharmaceutical products, natural remedies, as well as dietary supplements and medical devices. The company produces a variety of drugs, including antibiotics, antiviral medications, drugs for the treatment of cancer and cardiovascular diseases. In addition, Xiangxue Pharmaceutical is also involved in research and development and has introduced several groundbreaking products to the market in recent years. An example is the medication "XKS," which is used for the treatment of liver diseases. It was developed by Xiangxue Pharmaceutical and is the first Chinese drug to be approved by the European Medicines Agency. In the field of natural health products, the company offers an extensive range of products, including herbal extracts, traditional Chinese medicine products, and other natural remedies. These products are distributed in China and internationally and are popular among consumers seeking a natural alternative to traditional Western medicine. Xiangxue Pharmaceutical also utilizes advanced technologies to produce innovative and effective products. The company continuously invests in research and development and collaborates closely with universities and research institutions to develop new products and technologies. The company aims to be a leader in the field of modern medicine and natural health products in the Chinese and international markets. To achieve this goal, Xiangxue Pharmaceutical has established a strong presence in the market and continuously works on improving its business operations. Overall, Xiangxue Pharmaceutical's business model is well positioned to succeed in the Chinese and international markets. By combining innovative products, advanced technology, and effective marketing, the company has gained a strong position in the healthcare market and is expected to continue to expand in the future.

Xiangxue Pharmaceutical Co 배당금은 얼마입니까?

Xiangxue Pharmaceutical Co은(는) 연간 번의 배당을 통해 0 CNY의 배당금을 지급합니다.

Xiangxue Pharmaceutical Co이 얼마나 자주 배당을 지급하나요?

Xiangxue Pharmaceutical Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Xiangxue Pharmaceutical Co ISIN이 무엇입니까?

Xiangxue Pharmaceutical Co의 ISIN은 CNE100000Y92입니다.

Xiangxue Pharmaceutical Co 티커는 무엇인가요?

Xiangxue Pharmaceutical Co의 티커는 300147.SZ입니다.

Xiangxue Pharmaceutical Co이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Xiangxue Pharmaceutical Co은(는) 0.05 CNY 의 배당금을 지급했습니다. 이는 약 0.56 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Xiangxue Pharmaceutical Co은(는) 0 CNY의 배당금을 지급할 것으로 예상됩니다.